Heplisav-b 20 MCG/0.5 ML syrng 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F57PB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,626
Award facts
- Contract value 100% obligated
- $42,626.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $42,626 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for HEPLISAV-B 20 mcg/0.5 mL syringes. This is a competitive award with no set-aside designation, with performance expected to be completed by January 23, 2026, at the company's Conshohocken, Pennsylvania location. HEPLISAV-B is a recombinant hepatitis B vaccine, and this delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), a leading pharmaceutical distributor and healthcare solutions provider. The company maintains significant federal contracting relationships with the Defense Logistics Agency and other government healthcare systems, supplying a broad portfolio of medications, vaccines, medical devices, and specialized healthcare commodities. AmerisourceBergen's competitively awarded contracts consistently utilize firm fixed-price structures, demonstrating its capability to meet federal procurement requirements for essential medical products supporting military treatment facilities, veteran healthcare programs, and other government medical institutions.
Quick answers
Who was awarded contract SPE2DR26F57PB?
SPE2DR26F57PB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F57PB worth?
The government has obligated $42,626 on SPE2DR26F57PB.
Is contract SPE2DR26F57PB an order under another contract?
Yes. SPE2DR26F57PB is a delivery order under SPE2DR25D2006, an indefinite delivery contract.
Was contract SPE2DR26F57PB competed?
The extent of competition for SPE2DR26F57PB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award